F. Hoffmann-La Roche announced sales performance for January\u2013September 2026. Roche Holding holds a majority of shares, and the Company’s results include figures from the Roche Group. The published materials are posted on the Roche Group website.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4519","jir_company_name":"Chugai Pharmaceutical Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-10-22","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/4519-20261022-01.pdf","jir_short_summary":"F. Hoffmann-La Roche announced sales performance for January\u2013September 2026. Roche Holding holds a majority of shares, and the Company's results include figures from the Roche Group. The published materials are posted on the Roche Group website.","jir_summary":"### Overview\nThis report covers F. Hoffmann-La Roche's sales performance for January\u2013September 2026 and notes that Roche Holding holds the majority of Chugai Pharmaceutical Co., Ltd.'s shares. The published materials are available on the Roche Group website, and it should be noted that the Company's January\u2013September results include the Roche Group's figures.\n\n### Shareholding and Data Sources\nAs of June 30, 2026, Roche Holding, the parent company of the Roche Group, holds 59.89% of the Company's issued shares (61.12% voting rights). The published materials are posted on the Roche Group website, and the Company's period results include Roche Group figures.","jir_financial_highlights":"Period: January 1, 2026 \u2013 September 30, 2026 (Unknown)\nParent Ownership Percentage: 59.89% (Unknown)","jir_category":"","jir_hashtags":"#ChugaiPharmaceutical, #FHoffmannLaRoche, #IR","jir_key_figures":"Key Figure 1: Period January 1, 2026 \u2013 September 30, 2026\nKey Figure 2: Parent Shareholding Ratio 59.89%\nKey Figure 3: Voting Rights Ratio 61.12%","jir_meta_title":"Chugai Pharmaceutical Co., Ltd. \u2014 F. Hoffmann-La Roche 2026 Q3 Sales Performance | Jan\u2013Sep","jir_meta_description":"Chugai Pharmaceutical Co., Ltd. reports F. Hoffmann-La Roche's sales performance for Q3 2026 (Jan\u2013Sep). Explains Roche Holding's ownership and how the Group's figures are included. Official information available on the Roche Group site.","jir_og_title":"Chugai Pharmaceutical Co., Ltd. \u2014 F. Hoffmann-La Roche 2026 Q3 Sales Performance","jir_og_description":"Summary of F. Hoffmann-La Roche's sales performance for January\u2013September 2026 published by Chugai Pharmaceutical Co., Ltd., including the parent company's ownership status.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[]","ir_related_company":6836,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-133293","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n